Glen M Boyle Selected Research

Glen M Boyle Research Topics

Disease

35	Neoplasms (Cancer) 04/2024 - 04/2004
32	Melanoma (Melanoma, Malignant) 01/2023 - 06/2005
7	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2005
5	Squamous Cell Carcinoma of Head and Neck 01/2019 - 02/2005
4	Necrosis 04/2024 - 04/2004
4	Carcinogenesis 10/2019 - 08/2007
4	Breast Neoplasms (Breast Cancer) 04/2018 - 10/2010
4	Skin Neoplasms (Skin Cancer) 01/2016 - 04/2004
3	Infections 01/2022 - 09/2011
3	Inflammation (Inflammations) 03/2016 - 01/2011
2	Wounds and Injuries (Trauma) 01/2022 - 01/2020
2	Malaria 10/2016 - 09/2011
2	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2015 - 04/2014
2	Erythema 01/2014 - 02/2003
2	Ascites 01/2013 - 04/2010
2	Ovarian Epithelial Carcinoma 01/2013 - 04/2010
1	Hypersensitivity (Allergy) 04/2023
1	Skin Diseases (Skin Disease) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Schistosomiasis (Bilharziasis) 11/2020
1	Human Influenza (Influenza) 10/2019
1	Chagas Disease (American Trypanosomiasis) 01/2019
1	Echinococcosis (Hydatid Cysts) 01/2018

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 04/2024 - 06/2006
7	Transcription Factors (Transcription Factor)IBA 01/2022 - 09/2002
5	Protein Kinase CIBA 04/2024 - 10/2006
5	CytokinesIBA 01/2022 - 02/2009
5	Messenger RNA (mRNA)IBA 10/2019 - 02/2003
5	DiterpenesIBA 01/2019 - 04/2004
5	EstersIBA 01/2019 - 04/2004
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2010
4	MicroRNAs (MicroRNA)IBA 08/2016 - 03/2010
3	PhorbolsIBA 01/2022 - 01/2020
3	ChemokinesIBA 01/2022 - 10/2019
3	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 06/2004
3	3-ingenyl angelateIBA 01/2016 - 04/2004
3	Histones (Histone)IBA 12/2006 - 06/2004
2	Adenosine Triphosphate (ATP)IBA 04/2024 - 10/2022
2	CaspasesIBA 04/2024 - 06/2005
2	Peptides (Polypeptides)IBA 01/2023 - 10/2022
2	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2013
2	Protein Isoforms (Isoforms)IBA 01/2021 - 03/2015
2	Phosphotransferases (Kinase)IBA 11/2020 - 08/2014
2	Phorbol EstersIBA 10/2020 - 10/2006
2	EBC-46IBA 01/2020 - 01/2014
2	Protease Inhibitors (Protease Inhibitor)IBA 11/2019 - 01/2018
2	ChromatinIBA 02/2017 - 06/2005
2	Microphthalmia-Associated Transcription FactorIBA 01/2017 - 11/2011
2	Interferon Type IIBA 10/2016 - 09/2011
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2015 - 04/2014
2	Cadherins (E-Cadherin)IBA 08/2014 - 06/2009
2	H-cadherin (T-cadherin)IBA 08/2014 - 06/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2013 - 04/2010
2	Mitogen-Activated Protein KinasesIBA 10/2010 - 10/2006
2	Cytostatic AgentsIBA 10/2010 - 10/2006
2	Small Interfering RNA (siRNA)IBA 04/2009 - 02/2009
2	Histone Deacetylases (Histone Deacetylase)IBA 12/2006 - 06/2005
2	ParaffinIBA 07/2005 - 02/2005
2	Histone Deacetylase InhibitorsIBA 06/2005 - 06/2004
1	HMGB1 Protein (HMG1)IBA 04/2024
1	CalreticulinIBA 04/2024
1	Immune Checkpoint InhibitorsIBA 04/2024
1	Sunscreening Agents (Sunscreens)IBA 04/2023
1	AcetylcholinesteraseIBA 01/2023
1	TachykininsIBA 10/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	enzalutamideIBA 01/2021
1	AndrogensIBA 01/2021
1	AntigensIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Dihydrotestosterone (Androstanolone)IBA 01/2021
1	SteroidsIBA 01/2021
1	Praziquantel (Biltricide)FDA Link 11/2020
1	RhodiumIBA 10/2020
1	Sulfhydryl Compounds (Thiols)IBA 10/2020
1	Doxycycline (Periostat)FDA LinkGeneric 07/2020
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2020
1	Antiviral Agents (Antivirals)IBA 10/2019
1	LigandsIBA 10/2019
1	Anaphylatoxin C5a ReceptorIBA 10/2019
1	Complement C5a (Complement 5a)IBA 10/2019
1	Antiparasitic Agents (Antiparasitics)IBA 01/2019
1	benzonidazole (benznidazole)IBA 01/2019
1	LignansIBA 04/2018
1	epimethoxypiperitolIBA 04/2018
1	VenomsIBA 10/2017
1	Spider Venoms (Venom, Spider)IBA 10/2017
1	PolyaminesIBA 10/2017
1	EnzymesIBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	trametinibIBA 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2017

Therapy/Procedure

15	Therapeutics 10/2022 - 05/2011
8	Drug Therapy (Chemotherapy) 05/2015 - 04/2004
2	Radiotherapy 06/2005 - 04/2004
1	Immunotherapy 10/2022
1	Castration 01/2021